Back

Long-term dual antithrombotic therapy (DAT): is it efficient and safe in women?

Cardiovascular Research

16 June 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Meinrad Gawaz
Meinrad Gawaz

Author

Eberhard-Karls University of Tubingen Tuebingen , Germany

You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Single vs dual antiplatelet therapy after spontaneous coronary artery dissection
21 March 2026
thumbnail
Webinar
Women's heart health: what you need to know to help your female patients care for themselves better
16 June 2022
thumbnail
Congress Presentation
Efficacy and safety of P2Y12 inhibitors plus aspirin versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources